Brashears CB, Prudner BC, Rathore R, Caldwell KE, Dehner CA, Buchanan JL, et al
In vitro , GO@GSH-FA significantly restored viability in oxygen-glucose-deprived SH-SY5Y cells (from 31% up to near control levels), reduced inflammatory cytokines, and lowered intracellular ROS
Liposomal delivery enhances the bioavailability of both nutrients, potentially providing superior antioxidant support compared to individual supplements
Studied in: IGF-1 receptor (IGF-1R) binding research, IGFBP interaction studies, protein folding and disulfide structure analysis, and comparative work against native IGF-1 in controlled laboratory models
BNL: Project administration, Supervision, Writingreview and editing
The patients in this study had their medications covered by insurance, so cost may not have been a factor